Particle.news

Download on the App Store

Epigenetic Intrinsic Capacity Clock Validated and Adapted for Wider Healthspan Applications

Researchers hope the clock’s quantitative measure of functional decline will clear regulatory hurdles for aging therapies.

Image

Overview

  • The Intrinsic Capacity Clock quantifies aging through DNA methylation patterns linked to mobility, cognition, mental health, vision, hearing and nutrition.
  • The model was trained on INSPIRE-T cohort data and validated against the Framingham Heart Study, outperforming first- and second-generation clocks in predicting all-cause mortality.
  • A dried-blood spot assay is in development to enable non-invasive functional aging assessments in low- and middle-income countries.
  • The Buck Institute-led team and IHU HealthAge have been named XPRIZE Healthspan semifinalists, using the IC Clock to gauge responses to hybrid interventions combining ketone esters with ICOPE-INTENSE regimens.
  • Although the World Health Organization classified intrinsic capacity decline in ICD-11, US FDA approval for aging-targeted treatments remains pending, and the IC Clock could provide the quantifiable endpoints needed to bridge this regulatory gap.